XML 101 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Other expenses and income

12 Months Ended

Jun. 30, 2024

Other expenses and income

Other expenses and income

5 Other expenses and income

​

​	​	​	​	​	​	​	​
​		2024			2023		2022
for the year ended 30 June	​	Rm		​	Rm	​	Rm
Includes:	​	​		​		​
Derivative (gains)/losses1	​	​	(2 364)	​	(3 287)	​	18 325
Translation losses/(gains)	​	​	839	​	(2 728)	​	(693)
Trade and other receivables		​	485		(1 436)		(456)
Trade and other payables		​	241		171		(147)
Foreign currency loans		​	263		161		785
Other2	​	​	(150)	​	(1 624)	​	(875)
Exploration expenditure and feasibility costs	​	​	422	​	751	​	366
Professional fees	​	​	2 076	​	2 455	​	1 916
Expected credit losses raised/(reversed)		​	189		234		(39)

1 Relates mainly to the Group’s hedging activities and embedded derivatives. Refer to note 36.

2 Other translation gains includes translation of intergroup treasury balances.

​

Research and development expenditure amounting to R1 513 million (2023: R1 388 million; 2022: R1 160 million) was expensed and is included in Employee-related expenditure, Depreciation and amortisation and Other expenses and income in the Income statement.

X

- Definition

The disclosure of other operating income or expense. [Refer: Other operating income (expense)]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ssl_AnalysisOfOtherOperatingIncomeAndExpenseAbstract
Namespace Prefix:	ssl_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration